scholarly journals Transcatheter aortic valve implantation combined with other heart interventions: current status and future perspectives

Vessel Plus ◽  
2020 ◽  
Vol 2020 ◽  
Author(s):  
Ana Paula Tagliari ◽  
Maurizio Taramasso
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Current Status ◽  
Future Perspectives ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Future perspectives in transcatheter aortic valve implantation

2013 ◽  
Vol 168 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Christos V. Bourantas ◽  
Nicolas M. van Mieghem ◽  
Vasim Farooq ◽  
Osama I. Soliman ◽  
Stephan Windecker ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Future Perspectives ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status

2020 ◽  
Vol 15 ◽  
Author(s):  
Antonio Greco ◽  
Davide Capodanno
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Severe Aortic Stenosis ◽  
Current Status ◽  
Low Grade ◽  
Bleeding Events ◽  
Transcatheter Aortic Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
The Impact

Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic complications but it increases the risk of bleeding events. Current clinical guidelines are mostly driven by expert opinion and therefore yield low-grade recommendations. The optimal antithrombotic regimen following TAVI has yet to be determined and several randomised controlled trials assessing this issue are ongoing. The purpose of this article is to critically explore the impact of antithrombotic drugs, especially anticoagulants, on long-term clinical outcomes following successful TAVI.

Sign in / Sign up

Export Citation Format

Share Document